PET imaging of head and neck cancer

Daniela Maltais, Val J. Lowe

Research output: Chapter in Book/Report/Conference proceedingChapter


Head and neck cancers (HNC) are the sixth most common cancer worldwide. An estimated 630,000 patients are diagnosed annually, resulting in more than 350,000 deaths annually. The advent of positron emission tomography (PET) has improved the staging, treatment evaluation, and detection of recurrent disease in patients with HNSCC’s. The role of PET/CT in oncology has revolutionized our understanding and ability to diagnose and treat HNC’s. As with any modality limitations exist and these can only be addressed through more extensive research. Learning the anatomical landmarks and the distinction between normal and abnormal FDG physiologic uptake patterns will ensure that radiologists and nuclear medicine physicians make accurate decisions at all stages of patient care.

Original languageEnglish (US)
Title of host publicationNuclear Medicine and Molecular Imaging
Subtitle of host publicationVolume 1-4
Number of pages17
ISBN (Electronic)9780128229804
ISBN (Print)9780128229606
StatePublished - Jan 1 2022


  • FDG
  • Head and neck cancer
  • Larynx cancer
  • Nasopharynx cancer
  • Neck lymph
  • Node metastasis
  • Oropharynx cancer
  • PET/CT
  • Sinonasal cancer
  • Tongue cancer
  • Tonsil cancer
  • Treatment assessment

ASJC Scopus subject areas

  • General Agricultural and Biological Sciences
  • General Biochemistry, Genetics and Molecular Biology


Dive into the research topics of 'PET imaging of head and neck cancer'. Together they form a unique fingerprint.

Cite this